Home > Books > Combining Targeted Biological Agents with Radiotherapy: Current Status and Future Directions
Combining Targeted Biological Agents with Radiotherapy: Current Status and Future Directions
View PDF

Combining Targeted Biological Agents with Radiotherapy: Current Status and Future Directions

Publication Year: 2008
Edition: 1st
Authors/Editor: Small
Publisher: Springer Publishing Company
ISBN: 978-1-933-86434-1
Doody's Star Rating®:  Score: 75
  • Description
  • Details

Biologically targeted agents promise to be the next significant breakthrough in cancer therapy. Written by leading experts in the field, Combining Targeted Biological Agents with Radiotherapy is a comprehensive evaluation of the entire field.

Radiotherapy plays an integral role in cancer treatment. Approximately 60% of cancer patients will receive radiotherapy at some point in their treatment. A major improvement in patient outcomes occurs with the use of combined chemotherapy and radiotherapy. The combination of targeted biological agents with radiotherapy is the latest cutting-edge extension in cancer therapy for radiation oncologists.

Combining Targeted Biological Agents with Radiotherapy: Current Status and Future Directions is an overview of the current state of clinical and pre-clinical research in combining radiotherapy with targeted biological agents to fight cancer. The text provides a general overview of targeted agents, reviews the current clinical trials, and includes a look at the future of this state-of-the-art practice

The book begins with a general overview of the topic, including an introduction to the subject; the basic science rationale behind the two most important current targeted agents: epidermal growth factor (EGFR) receptors and vascular epithelial growth factor (VEGF) receptors; the dermatologic manifestations of targeted agents; and an introduction to radioimmunotherapy a treatment that has the ability to combine targeted agents directly with radiotherapy. The second half of the book focuses on specific disease sites, including malignant gliomas, head and neck, lung, pancreatic, cervical, and endometrial cancers.

  • Platform:
    Ovid
  • Publisher: Springer Publishing Company
  • Product Type: Book
  • Author/Editor: Small
  • ISBN: 978-1-933-86434-1
  • Specialty:
    Hematology
    Oncology
    Radiology
  • Language: English
  • Edition: 1st
  • Pages: 226
  • Illustrations: 0
  • Year: 2008
  • Doody's Star Rating®:  Score: 75

Free Instant Access
This Month

JOTM
Embase® Embase increases the discovery of biomedical evidence to support critical life sciences functions, delivering relevant, up-to-date biomedical information to the global biomedical research community.
JOTM
Food Science & Technology Abstracts FSTA® covers topics relating to every aspect of the food chain including all the major food commodities plus biotechnology, microbiology, food safety, additives, nutrition, packaging and pet foods.
JOTM
American Journal of Gastroenterology As the leading clinical journal covering gastroenterology and hepatology, AJG provides practical and professional support for clinicians dealing with the gastroenterological disorders seen most often in patients.
JOTM
Evidence-Based Practice Evidence-Based Practice is a quarterly journal focused on topics relevant to the daily practice of family medicine and contains content addressing timely and pertinent questions related to patient care.

Noteworthy

Doody's Featured Books
Access Device Standards of Practice for Oncology Nursing
An essential resource for nurses practicing in a wide range of settings to ensure safe, effective care of patients with VADs.

Fundamentals of High-Resolution Lung CT: Common Findings, Common Patterns, Common Diseases, and Differential Diagnosis
Provides a straightforward guide to understanding the high-resolution lung CT (HRCT) assessment of diffuse lung diseases.